Michael Robert Gold

Cardiac Defibrillators and Heart Failure

Fergie J. Losiniecki, George S. Waits, Michael Robert Gold

us (code pays fourni par la source)

Acute Thrombosis During Atrial Leadless Pacemaker Implantation

Bing Fu, Yiran Hu, Yu Jiang, Xiaohui Ning et autres

BACKGROUND: Atrial leadless pacemakers (LPs) provide physiological pacing, but they still carry procedural risks. CASE SUMMARY: We report the case of an elderly immobilized patient with sinus node dysfunction but without atrioventricular conduction block, who underwent atrial LP implantation (Aveir AR). The …

cn, us (code pays fourni par la source)

Major Bleeding With Apixaban vs Aspirin

Deborah M. Siegal, Christian Sticherling, Jeff S. Healey, William F. McIntyre et autres

Importance: The Apixaban for the Reduction of Thromboembolism in Patients With Device-Detected Subclinical Atrial Fibrillation (ARTESiA) randomized clinical trial showed that in patients with subclinical atrial fibrillation (SCAF) apixaban, compared with aspirin, reduced stroke/systemic embolism but increased major bleeding. Objectives: To characterize …

ca, ch, dk, be, us, de, gb (code pays fourni par la source)

Abstract 4339399: Incidence and predictors of Monomorphic Ventricular Tachycardia in Three Major Subcutaneous ICD Trials

Pier David Lambiase, Michael Robert Gold, Ulrika Maria Birgersdotter-Green, Lars Eckardt et autres

Background: The subcutaneous ICD (S-ICD) is currently contraindicated for patients (pts) who have monomorphic ventricular tachycardia (MVT) that can be terminated by anti-tachycardia pacing (ATP). Discriminating S-ICD pts who subsequently present with MVT can help identify those who would benefit from a …

gb, us, de, nl, fr, it (code pays fourni par la source)

Validation of an automated premature ventricular contraction mapping algorithm

Yuji Ishida, Michael Robert Gold, Joshua Payne, Adam R. Bainey et autres

Abstract Background Catheter mapping and ablation of premature ventricular contractions (PVCs) requires accurate annotation of earliest local activation time (LAT), but displacement in catheter position between sinus rhythm (SR) and the PVC complicates three-dimensional mapping localization. An automated algorithm to annotate LAT …

jp, us (code pays fourni par la source)

Premature Ventricle Contraction Ablation in Cardiac Sarcoidosis

Brett Matthew Tomashitis, Zain S. Gowani, Leah A. John, Josh Payne et autres

us (code pays fourni par la source)

Cost-effectiveness of apixaban vs. aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial

Andre L. Lamy, Roopinder Kaur Sandhu, Wesley Tong, William F. McIntyre et autres

AIMS: Apixaban was superior to aspirin for the prevention of stroke or systemic embolism in participants with subclinical atrial fibrillation (SCAF) in the Apixaban for the Reduction of Thromboembolism in Patients With Device-Detected Subclinical Atrial Fibrillation trial. This was especially true for …

ca, us, gb, dk, hu, de, nl, no, se, cz, es, ch, cl (code pays fourni par la source)

Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: A subgroup analysis of ARTESiA

Lucas Yixi Xing, Renato D. Lópes, William F. McIntyre, Roopinder Kaur Sandhu et autres

dk, ca, us, es, nl, fr, hu, de (code pays fourni par la source)

Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: Insights from the ARTESiA trial

Giuseppe Boriani, William F. McIntyre, Chinthanie F. Ramasundarahettige, Marco Proietti et autres

it, ca, us, dk, es, fr (code pays fourni par la source)

Win ratio analysis of the REVERSE cardiac resynchronization trial

Michael Robert Gold, William T. Abraham, Javed Butler, Michael R. Zile et autres

us, ie, se (code pays fourni par la source)

Incidence and predictors of major bleeding among patients receiving apixaban or aspirin for subclinical atrial fibrillation: insights from the ARTESiA sub-analysis

Deborah M. Siegal, Jeff S. Healey, William F. McIntyre, David Conen et autres

Abstract Background ARTESiA (Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation) was a randomized double-blind, double-dummy trial which showed that apixaban, compared with aspirin, reduced stroke and systemic embolism, but increased major bleeding in patients aged ≥55 …

ca, us, dk (code pays fourni par la source)

PO-06-061 QRSD/LVEDD ELIMINATES SEX-SPECIFIC DIFFERENCES IN THE EFFICACY OF CARDIAC RESYNCHRONIZATION THERAPY

Jiangang Zou, Zhang Enrui, Fengwei Zou, Yangxin Chen et autres